Displaying results 1 - 3 of 3
Clear search
Lucida Medical Ltd announces a distribution agreement with Sectra to offer Pi AI technology to help diagnose prostate cancer
Lucida Medical announces that it has signed a distribution agreement with international medical imaging IT and cybersecurity company Sectra.
Somerset’s NHS pioneers clinical use of AI software to transform prostate cancer diagnosis
A ground breaking way of supporting doctors to diagnose prostate cancer using the latest artificial intelligence (AI) technology has launched in Somerset.
Lucida Medical and Hampshire Hospitals NHS Foundation Trust announce major study on AI for prostate cancer
Lucida Medical Ltd, the Cambridge-based start-up, and Hampshire Hospitals NHS Foundation Trust (HHFT), have initiated a ground-breaking, collaborative multi-centre research project. This is the first retrospective study in the UK to validate the use of AI to help identify prostate cancer using real-world data from a range of hospitals and scanner types. It will demonstrate the potential of this…